Meet with representatives in the Clinical Trials Awareness Area just outside the Exhibit Hall on the Upper Level.

Bayer HealthCare
Booth 9

Bayer HealthCare is one of the world’s leading, innovative companies in the health care and medical products industry and combines the activities of the Animal Health, Consumer Care, Medical Care, and Pharmaceuticals divisions. As a specialty pharmaceutical company, Bayer HealthCare provides products for Cardiopulmonary, Hematology, Neurology, Oncology, and Women’s Healthcare.

Biogen
Booth 11

Biogen’s research efforts are built on understanding the biology of complex diseases and developing potential therapies for patients with serious illnesses that currently have few, if any, treatment options. To this end, Biogen is currently investigating compound STX-100 (aka BG00011) for the treatment of idiopathic pulmonary fibrosis (IPF). It is our goal to identify and validate novel targets that will catalyze the discovery of important new approaches to treating disease.

Genentech, Inc.
Booth 13

Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 35 years. At Genentech, we use human genetic information to discover, develop, manufacture, and commercialize medicines to treat patients with serious or life-threatening medical conditions. Today, we are among the world’s leading biotech companies, with multiple products on the market and a promising development pipeline.

Insmed, Inc.
Booth 8

Insmed Incorporated is a biopharmaceutical company dedicated to improving the lives of patients battling serious lung diseases. Insmed is focused on the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections.

Vertex Pharmaceuticals, Inc.
Booth 10

Vertex is a global biotechnology company that aims to discover, develop, and commercialize innovative medicines so people with serious diseases can lead better lives. In addition to our clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases. Founded in 1989 in Cambridge, MA, Vertex today has research and development sites and commercial offices in the United States, Europe, Canada, and Australia.